Hence, in CLL the majority of the primary driver mutations are unrelated to BCR signaling proteins with alterations affecting the MIR15A and MIR16-1, ATM, BIRC3, NOTCH, SF3B1, and TP53 genes being highly prevalent (111–113). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.